![]()
PhRMA Statement on Health Care Reform
OPKO Health, Inc. today announced the signing of a letter of intent to collaborate with the Centro de Investigación y …Click Here to Read More
[NEWS]
Contact: Michael Yarus yarus@colorado.edu 303-492-8376 University of Colorado at Boulder An extremely small RNA molecule created by a University of Colorado at Boulder team can catalyze a key reaction needed to synthesize proteins, the building blocks of life. The findings could be a substantial step toward understanding “the very o…
University of Central Florida professor Henry Daniell has developed a groundbreaking way to produce ethanol from waste products such as …Click Here to Read More
Santa Fe College’s new Perry Center for Emerging Technologies in Alachua is sponsoring an open house from 6:30 to 7:30 …Click Here to Read More
The U.S. government broadened the definition of a human embryonic stem cell on Friday, helping qualify several corporate and academic experiments …Click Here to Read More
The GET Conference 2010 marks the last chance in history to collect everyone with a personal genome sequence on the …Click Here to Read More
BioFlorida, the statewide trade association founded in 1997 to advance Florida’s bioscience industry, has approved a plan to launch The …Click Here to Read More
[NEWS]
Contact: Andy Fell ahfell@ucdavis.edu 530-752-4533 University of California – Davis Yields of biodiesel from oilseed crops such as safflower could be increased by up to 24 percent using a new process developed by chemists at UC Davis. The method converts both plant oils and carbohydrates into biodiesel in a single process, and should also impr…
A machine that prints organs is coming to market
THE great hope of transplant surgeons is that they will, one day, be able to order replacement body parts on demand. At the moment, a patient may wait months, sometimes years, for an organ from a suitable donor. During that time his condition may worsen. He may even die. The ability to make organs as they are needed would not only relieve suffering but also save lives. And that possibility may be closer with the arrival of the first commercial 3D bio-printer for manufacturing human tissue and organs.
The new machine, which costs around $200,000, has been developed by Organovo, a company in San Diego that specialises in regenerative medicine, and Invetech, an engineering and automation firm in Melbourne, Australia. One of Organovo’s founders, Gabor Forgacs of the University of Missouri, developed the prototype on which the new 3D bio-printer is based. The first production models will soon be delivered to research groups which, like Dr Forgacs’s, are studying ways to produce tissue and organs for repair and replacement. At present much of this work is done by hand or by adapting existing instruments and devices. …